Cancer Research Prevention Award  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagata, H.
Right arrow Articles by Hibi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagata, H.
Right arrow Articles by Hibi, T.
[Cancer Research 64, 8239-8248, November 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Limited Capability of Regional Lymph Nodes to Eradicate Metastatic Cancer Cells

Hiroshi Nagata1, Tsunenori Arai2, Yusuke Soejima2, Hidekazu Suzuki1, Hiromasa Ishii1 and Toshifumi Hibi1

1 Department of Internal Medicine, School of Medicine, Keio University and 2 Faculty of Science and Technology, Keio University, Tokyo, Japan

The capacity of lymph nodes to eradicate cancer is a controversial issue. The purpose of this study was to determine the interplay between tumor growth and host resistance at early stages of lymph node metastasis. A metastasis model was made in the rat mesenteric lymph node, and migration of cancer cells was visualized in vivo. The lymph node was removed for histologic analysis and cytokine measurement. Migrant cancer cells were initially arrested in the marginal sinus. After an initial increase, the number of cancer cells in the marginal sinus declined until 48 hours after inoculation. Germinal centers and lymphoid cells in the medulla proliferated before 48 hours. ED3+ macrophages incorporated apoptotic cancer cells, but significant cancer proliferation occurred after 4 days. Lymph nodes depleted of macrophages were massively invaded by cancer cells. Tumor necrosis factor {alpha} and interleukin (IL)-1ß in the nodes transiently increased after 1 hour and 3 hours, respectively, and were expressed in ED3+ and ED2+ macrophages, respectively. These changes were followed by a transient increase in IL-2. Interferon-{gamma} and IL-12 did not increase during the early stages of metastasis, but they decreased after 48 hours. In conclusion, the marginal sinus constitutes a mechanical barrier against cancer cell passage. Early pathological manifestations in the regional lymph node are consistent with those in cancer patients with improved survival. Parasinus macrophages play a role in the transient antimetastatic capability of the node, and cytokines secreted by these cells increased at the early stages of metastasis. Deterioration of cytokine induction may be responsible for subsequent cancer proliferation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Kawai, M. Kaidoh, and T. Ohhashi
MDA-MB-231 produces ATP-mediated ICAM-1-dependent facilitation of the attachment of carcinoma cells to human lymphatic endothelial cells
Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1123 - C1132.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Yanagita, S. Natsugoe, Y. Uenosono, H. Arima, T. Kozono, K. Ehi, T. Arigami, H. Higashi, and T. Aikou
Morphological Distribution of Metastatic Foci in Sentinel Lymph Nodes with Gastric Cancer
Ann. Surg. Oncol., March 1, 2008; 15(3): 770 - 776.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
EDITOR'S CHOICE 42(2)
Vet. Pathol., February 1, 2005; 42(2): 239 - 240.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.